M Mokomane1, M D Esona2, M D Bowen2, J E Tate2, A P Steenhoff3, K Lechiile4, S Gaseitsiwe5, L M Seheri6, N B Magagula6, G Weldegebriel7, J M Pernica8, J M Mwenda9, I Kasvosve10, U D Parashar2, D M Goldfarb11. 1. Department of Medical Laboratory Science, Faculty of Health Sciences, University of Botswana, Gaborone, Botswana; Botswana National Health Laboratory, Gaborone, Botswana. Electronic address: mbafana@gov.bw. 2. Centers for Disease Control and Prevention, Atlanta, GA, USA. 3. The Children's Hospital of Philadelphia, USA. 4. Botswana-UPenn Partnership, Gaborone, Botswana. 5. Botswana-Harvard AIDS Institute Partnership, Gaborone, Botswana. 6. WHO Regional Rotavirus Reference Laboratory, Diarrhoeal Pathogens Research Unit, Sefako Makgatho Health Sciences University, South Africa. 7. WHO IST East and Southern Africa, Harare, Zimbabwe. 8. McMaster University, Hamilton, Canada. 9. African Rotavirus Surveillance Network, Immunization, Vaccines and Development Cluster, WHO African Regional Office, Brazzaville, Congo. 10. Botswana National Health Laboratory, Gaborone, Botswana. 11. University of British Columbia, Vancouver, Canada.
Abstract
BACKGROUND: Globally, rotavirus is the leading cause of acute gastroenteritis (AGE) in children aged <5 years. Botswana introduced the monovalent rotavirus vaccine (Rotarix) in July 2012. To study the impact of this vaccine on rotavirus genotypes circulating in Botswana, a comparison of the genotypes pre-vaccination (2011-2012) and post-vaccination (2013-2018) periods was conducted. SUBJECTS AND METHODS: Residual samples from 284 children <5 years of age that tested positive for rotavirus by enzyme immunoassay were genotyped. One hundred and five samples were from the pre-vaccination period and 179 were from the post-vaccination period. Genotyping was performed using two multiplexed one-step reverse transcription polymerase chain reaction (RT-PCR) assays for the amplification and genotyping of rotavirus VP7 (G) and VP4 (P) genes. RESULTS: Prior to vaccine introduction, the predominant rotavirus circulating genotypes were G9P[8] (n = 63, 60%) and G1P[8] (n = 22, 21%). During the vaccine period, G2P[4] was the predominant genotype (n = 49, 28%), followed by G9P[8] (n = 40, 22%) and G1P[8] (n = 33, 18.5%). There was a significant decline in the prevalence of G9P[8] (p = 0.001) in the post-vaccination period. There was also a notable decline in G1P[8]. A spike in G2P[4] was observed in 2013, one year post-vaccine introduction. Rotavirus strain G3P[4] (n = 8) was only detected in the post-vaccine introduction period. In 2018 there was a marked increase in genotype G3P[8] (p = 0.0003). CONCLUSIONS: The distribution of circulating rotavirus genotypes in Botswana changed after vaccine implementation. Further studies are needed to examine whether these changes are related to vaccination or simply represent natural secular variation.
BACKGROUND: Globally, rotavirus is the leading cause of acute gastroenteritis (AGE) in children aged <5 years. Botswana introduced the monovalent rotavirus vaccine (Rotarix) in July 2012. To study the impact of this vaccine on rotavirus genotypes circulating in Botswana, a comparison of the genotypes pre-vaccination (2011-2012) and post-vaccination (2013-2018) periods was conducted. SUBJECTS AND METHODS: Residual samples from 284 children <5 years of age that tested positive for rotavirus by enzyme immunoassay were genotyped. One hundred and five samples were from the pre-vaccination period and 179 were from the post-vaccination period. Genotyping was performed using two multiplexed one-step reverse transcription polymerase chain reaction (RT-PCR) assays for the amplification and genotyping of rotavirus VP7 (G) and VP4 (P) genes. RESULTS: Prior to vaccine introduction, the predominant rotavirus circulating genotypes were G9P[8] (n = 63, 60%) and G1P[8] (n = 22, 21%). During the vaccine period, G2P[4] was the predominant genotype (n = 49, 28%), followed by G9P[8] (n = 40, 22%) and G1P[8] (n = 33, 18.5%). There was a significant decline in the prevalence of G9P[8] (p = 0.001) in the post-vaccination period. There was also a notable decline in G1P[8]. A spike in G2P[4] was observed in 2013, one year post-vaccine introduction. Rotavirus strain G3P[4] (n = 8) was only detected in the post-vaccine introduction period. In 2018 there was a marked increase in genotype G3P[8] (p = 0.0003). CONCLUSIONS: The distribution of circulating rotavirus genotypes in Botswana changed after vaccine implementation. Further studies are needed to examine whether these changes are related to vaccination or simply represent natural secular variation.
Authors: Eva D João; Benilde Munlela; Assucênio Chissaque; Jorfélia Chilaúle; Jerónimo Langa; Orvalho Augusto; Simone S Boene; Elda Anapakala; Júlia Sambo; Esperança Guimarães; Diocreciano Bero; Marta Cassocera; Idalécia Cossa-Moiane; Jason M Mwenda; Isabel Maurício; Hester G O'Neill; Nilsa de Deus Journal: Pathogens Date: 2020-08-19
Authors: Mike J Mwanga; Jennifer R Verani; Richard Omore; Jacqueline E Tate; Umesh D Parashar; Nickson Murunga; Elijah Gicheru; Robert F Breiman; D James Nokes; Charles N Agoti Journal: Pathogens Date: 2020-11-24
Authors: Peter N Mwangi; Nicola A Page; Mapaseka L Seheri; M Jeffrey Mphahlele; Sandrama Nadan; Mathew D Esona; Benjamin Kumwenda; Arox W Kamng'ona; Celeste M Donato; Duncan A Steele; Valantine N Ndze; Francis E Dennis; Khuzwayo C Jere; Martin M Nyaga Journal: Microb Genom Date: 2022-04
Authors: José Paulo Gagliardi Leite; Marcia Terezinha Baroni de Moraes; Carina Pacheco Cantelli; Alvaro Jorge Velloso; Rosane Maria Santos de Assis; José Júnior Barros; Francisco Campello do Amaral Mello; Denise Cotrim da Cunha; Patricia Brasil; Johan Nordgren; Lennart Svensson; Marize Pereira Miagostovich Journal: Sci Rep Date: 2020-04-24 Impact factor: 4.379
Authors: Filomena Manjate; Eva D João; Percina Chirinda; Marcelino Garrine; Delfino Vubil; Nélio Nobela; Karen Kotloff; James P Nataro; Tacilta Nhampossa; Sozinho Acácio; Jacqueline E Tate; Umesh Parashar; Jason M Mwenda; Pedro L Alonso; Martin Nyaga; Celso Cunha; Inácio Mandomando Journal: Viruses Date: 2022-01-12 Impact factor: 5.048